Marc Chévrier

4.0k citations
42 papers · 2.6k · 1 hit paper · h-index 20

Impact in

  • Rheumatology top 0.5%
    • Systemic Lupus Erythematosus Research
  • Immunology top 2%
    • T-cell and B-cell Immunology
    • Psoriasis: Treatment and Pathogenesis
    • Atherosclerosis and Cardiovascular Diseases

Papers in

Marc Chévrier

38 papers receiving 2.6k citations

Marc Chévrier's Hit Papers

A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study of belimumab in patients with active systemic lupus erythematosus 2009 · 412 citations
4120+5+11Years since publication100200300400

Peers

Marc Chévrier
Comparison fields: 5 of 107
  • Rheumatology 1.2k
  • Immunology 1.3k
  • Radiology, Nuclear Medicine and Imaging 512
  • Dermatology 188
  • Pathology and Forensic Medicine 134
Replace Ernest Brahn with:
Ernest Brahn United States
Charles Pendley United States
Cheryl Nickerson‐Nutter United States
Florence W. L. Tsui Canada
Scott Mellis United States
Garvin L. Warner United States
Mary C. Wacholtz United States
Nandini Kishore United States
Dana P. Ascherman United States
Yasmeen Ahmad United Kingdom
Marc Chévrier relative to Ernest Brahn United States Ernest Brahn's profile →
Citations per field
00.5×
Ernest Brahn · 1×
Citations per year

Countries citing papers authored by Marc Chévrier

Since Specialization
Citations

This map shows the geographic impact of Marc Chévrier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Chévrier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Chévrier more than expected).

Fields of papers citing papers by Marc Chévrier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Chévrier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Chévrier. The network helps show where Marc Chévrier may publish in the future.

Co-authors

The 25 scholars most cited alongside Marc Chévrier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marc Chévrier Line = papers co-authored together Marc Chévrier links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study of belimumab in patients with active systemic lupus erythematosus
Hit paper breakdown →
2009412
2 2009345
3 2008333
4 2015275
5 2018238
6 1993171
7 1996157
8 201095
9 201492
10 200576
11
PSOLAR: design, utility, and preliminary results of a prospective, international, disease-based registry of patients with psoriasis who are receiving, or are candidates for, conventional systemic treatments or biologic agents.
201266
12 201859
13 201746
14 201146
15 201942
16 199128
17 202123
18 202022
19 201822
20
Effect of infliximab on health-related quality of life and disease activity by body region in patients with moderate-to-severe psoriasis and inadequate response to etanercept: results from the PSUNRISE trial.
201320

About Marc Chévrier

Marc Chévrier is a scholar working on Rheumatology, Immunology, Sociology and Political Science, Epidemiology and Molecular Biology, having authored 42 papers that have together received 2.6k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (12 papers), Psoriasis: Treatment and Pathogenesis (9 papers), Canadian Identity and History (3 papers), Dermatology and Skin Diseases (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Mass Spectrometry Techniques and Applications (2 papers), Cytokine Signaling Pathways and Interactions (2 papers) and Inflammatory Bowel Disease (2 papers). The work is most often cited by research in Rheumatology (1.2k citations), Immunology (1.3k citations), Radiology, Nuclear Medicine and Imaging (512 citations), Dermatology (188 citations) and Pathology and Forensic Medicine (134 citations). Marc Chévrier has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include William Stohl, Winn Chatham, Michelle Petri, William W. Freimuth, Robert J. Cotter, Gerald W. Hart, W. Joseph McCune, Richard Furie, Daniel J. Wallace and Ellen M. Ginzler. Their work appears in journals such as British Journal of Dermatology, Annals of the Rheumatic Diseases, Journal of the American Academy of Dermatology, Arthritis & Rheumatology and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact